Your search:
161 result(s) in 0.02 s
-
DUK10142573_007
NEWS - Coronavirus: Kein Impfstoff für Schwerpunktimpfung in Kölner Stadtbezirk Meschenich
Die Schwerpunktimpfung in Kölner Stadtbezirken mit hoher Inzidenz laufen vorerst aus. Der Grund: Es fehlt Impfstoff. Im Bild eine Wohnanlage am Kölnberg im Stadtteil Meschenich. In dem sozialen Brennpunkt wurde Freitag und Samstag eine Sonderimpfung angesetzt. (Themenbild, Symbolbild) Köln, 10.05.2021 *** Local Caption *** 32619332
(c) Dukas -
DUK10138668_005
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441463
(c) Dukas -
DUK10142573_001
NEWS - Coronavirus: Kein Impfstoff für Schwerpunktimpfung in Kölner Stadtbezirk Meschenich
Die Schwerpunktimpfung in Kölner Stadtbezirken mit hoher Inzidenz laufen vorerst aus. Der Grund: Es fehlt Impfstoff. Im Bild eine Wohnanlage am Kölnberg im Stadtteil Meschenich. In dem sozialen Brennpunkt wurde Freitag und Samstag eine Sonderimpfung angesetzt. (Themenbild, Symbolbild) Köln, 10.05.2021 *** Local Caption *** 32619335
(c) Dukas -
DUK10142573_014
NEWS - Coronavirus: Kein Impfstoff für Schwerpunktimpfung in Kölner Stadtbezirk Meschenich
Die Schwerpunktimpfung in Kölner Stadtbezirken mit hoher Inzidenz laufen vorerst aus. Der Grund: Es fehlt Impfstoff. Im Bild eine Wohnanlage am Kölnberg im Stadtteil Meschenich. In dem sozialen Brennpunkt wurde Freitag und Samstag eine Sonderimpfung angesetzt. (Themenbild, Symbolbild) Köln, 10.05.2021 *** Local Caption *** 32619348
(c) Dukas -
DUK10142573_012
NEWS - Coronavirus: Kein Impfstoff für Schwerpunktimpfung in Kölner Stadtbezirk Meschenich
Die Schwerpunktimpfung in Kölner Stadtbezirken mit hoher Inzidenz laufen vorerst aus. Der Grund: Es fehlt Impfstoff. Im Bild eine Wohnanlage am Kölnberg im Stadtteil Meschenich. In dem sozialen Brennpunkt wurde Freitag und Samstag eine Sonderimpfung angesetzt. (Themenbild, Symbolbild) Köln, 10.05.2021 *** Local Caption *** 32619331
(c) Dukas -
DUK10138668_010
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441469
(c) Dukas -
DUK10142573_008
NEWS - Coronavirus: Kein Impfstoff für Schwerpunktimpfung in Kölner Stadtbezirk Meschenich
Die Schwerpunktimpfung in Kölner Stadtbezirken mit hoher Inzidenz laufen vorerst aus. Der Grund: Es fehlt Impfstoff. Im Bild eine Wohnanlage am Kölnberg im Stadtteil Meschenich. In dem sozialen Brennpunkt wurde Freitag und Samstag eine Sonderimpfung angesetzt. (Themenbild, Symbolbild) Köln, 10.05.2021 *** Local Caption *** 32619351
(c) Dukas -
DUK10138668_001
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441472
(c) Dukas -
DUK10138668_008
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441471
(c) Dukas -
DUK10138668_002
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441476
(c) Dukas -
DUK10138668_009
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441474
(c) Dukas -
DUK10138668_004
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441461
(c) Dukas -
DUK10138668_003
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441458
(c) Dukas -
DUK10139198_001
NEWS - Coronavirus: Visualisierung Impfung
die Mainzer Firma Biontech hat einen potenten Impfstoff gegen das Coronavirus gefunden - Symbolbild: CGI-Visualisierung: Impfung, Coronavirus Covid 19, SARS 2/ the German company Biontech has found a potent vaccine against the corona virus- symbolic image of a vaccination against the new Corona virus Covid 19, cgi, Credit:Jens Knappe / 360-berlin Jens Knappe / Avalon
(c) Dukas -
DUK10142573_009
NEWS - Coronavirus: Kein Impfstoff für Schwerpunktimpfung in Kölner Stadtbezirk Meschenich
Die Schwerpunktimpfung in Kölner Stadtbezirken mit hoher Inzidenz laufen vorerst aus. Der Grund: Es fehlt Impfstoff. Im Bild eine Wohnanlage am Kölnberg im Stadtteil Meschenich. In dem sozialen Brennpunkt wurde Freitag und Samstag eine Sonderimpfung angesetzt. (Themenbild, Symbolbild) Köln, 10.05.2021 *** Local Caption *** 32619350
(c) Dukas -
DUK10139198_004
NEWS - Coronavirus: Visualisierung Impfung
die Mainzer Firma Biontech hat einen potenten Impfstoff gegen das Coronavirus gefunden - Symbolbild: CGI-Visualisierung: Impfung, Coronavirus Covid 19, SARS 2/ the German company Biontech has found a potent vaccine against the corona virus- symbolic image of a vaccination against the new Corona virus Covid 19, cgi, Credit:Jens Knappe / 360-berlin Jens Knappe / Avalon
(c) Dukas -
DUK10139198_006
NEWS - Coronavirus: Visualisierung Impfung
die Mainzer Firma Biontech hat einen potenten Impfstoff gegen das Coronavirus gefunden - Symbolbild: CGI-Visualisierung: Impfung, Coronavirus Covid 19, SARS 2/ the German company Biontech has found a potent vaccine against the corona virus- symbolic image of a vaccination against the new Corona virus Covid 19, cgi, Credit:Jens Knappe / 360-berlin Jens Knappe / Avalon
(c) Dukas -
DUK10139198_003
NEWS - Coronavirus: Visualisierung Impfung
die Mainzer Firma Biontech hat einen potenten Impfstoff gegen das Coronavirus gefunden - Symbolbild: CGI-Visualisierung: Impfung, Coronavirus Covid 19, SARS 2/ the German company Biontech has found a potent vaccine against the corona virus- symbolic image of a vaccination against the new Corona virus Covid 19, cgi, Credit:Jens Knappe / 360-berlin Jens Knappe / Avalon
(c) Dukas -
DUK10138668_007
NEWS - Coronavirus: Impfstoff gegen Coronavirus COVID-19 (Symbolbilder)
Impfstoff gegen Coronavirus COVID-19 Coronavirus Corona Vacccin Impfung
vaccine against coronavirus COVID-19 coronavirus coronavacccin Vaccination
/ 091220 *** Local Caption *** 31441459
(c) Dukas -
DUK10139198_005
NEWS - Coronavirus: Visualisierung Impfung
die Mainzer Firma Biontech hat einen potenten Impfstoff gegen das Coronavirus gefunden - Symbolbild: CGI-Visualisierung: Impfung, Coronavirus Covid 19, SARS 2/ the German company Biontech has found a potent vaccine against the corona virus- symbolic image of a vaccination against the new Corona virus Covid 19, cgi, Credit:Jens Knappe / 360-berlin Jens Knappe / Avalon
(c) Dukas -
DUK10139198_002
NEWS - Coronavirus: Visualisierung Impfung
die Mainzer Firma Biontech hat einen potenten Impfstoff gegen das Coronavirus gefunden - Symbolbild: CGI-Visualisierung: Impfung, Coronavirus Covid 19, SARS 2/ the German company Biontech has found a potent vaccine against the corona virus- symbolic image of a vaccination against the new Corona virus Covid 19, cgi, Credit:Jens Knappe / 360-berlin Jens Knappe / Avalon
(c) Dukas -
DUK10147310_014
NEWS - Coronavirus: Vierte Impfdosen für über 60-Jährige in Israel
Mandatory Credit: Photo by Debbie Hill/UPI/Shutterstock (12685258p)
An Israeli health worker holds vials of Moderna and Pfizer BioNTech vaccines for the elderly in the Meuhedet Clinic in Jerusalem on Monday, January 3, 2022. Israel is the first in the world to administer the fourth COVID-19 vaccination for people over 60 and health workers.
COVID-19 vaccination, Jerusalem, Israel - 03 Jan 2022
(c) Dukas -
DUK10147310_005
NEWS - Coronavirus: Vierte Impfdosen für über 60-Jährige in Israel
Mandatory Credit: Photo by Debbie Hill/UPI/Shutterstock (12685258k)
Vials of Moderna and Pfizer BioNTech COVID-19 vaccine set in the Meuhedet Clinic in Jerusalem on Monday, January 3, 2022. Israel is the first in the world to administer the fourth COVID-19 vaccination for people over 60 and health workers.
COVID-19 vaccination, Jerusalem, Israel - 03 Jan 2022
(c) Dukas -
DUK10138770_002
NEWS - Coronavirus: COVID-19-Impfstoff trifft in San Diego ein
Mandatory Credit: Photo by Sam Hodgson/The San Diego Union-Tribune/Shutterstock (11550113f)
Mariana Venegas, right, the vaccine and surge coordinator for the county of San Diego and Rachel Jonas, left, a public health nurse, wheel doses of the Pfizer COVID-19 vaccine that arrived early Monday in San Diego County to pass them off to Nirmal Patel, not pictured, the director of pharmacy services, ambulatory pharmacy at Scripps Health, at an undisclosed county building
COVID-19 Vaccine Arrival, San Diego, Los Angeles, California, USA - 14 Dec 2020 -
DUK10147310_004
NEWS - Coronavirus: Vierte Impfdosen für über 60-Jährige in Israel
Mandatory Credit: Photo by Debbie Hill/UPI/Shutterstock (12685258l)
An Israeli health worker prepares a fourth Pfizer BioNTech vaccine for an elderly man in the Meuhedet Clinic in Jerusalem on Monday, January 3, 2022. Israel is the first in the world to administer the fourth COVID-19 vaccination for people over 60 and health workers.
COVID-19 vaccination, Jerusalem, Israel - 03 Jan 2022
(c) Dukas -
DUK10141218_010
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, the vials with serum and blood. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699871
(c) Dukas -
DUK10141218_006
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher removes serum from the vial with blood. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699870
(c) Dukas -
DUK10138770_010
NEWS - Coronavirus: COVID-19-Impfstoff trifft in San Diego ein
Mandatory Credit: Photo by Sam Hodgson/The San Diego Union-Tribune/Shutterstock (11550113b)
Mariana Venegas, right, the vaccine and surge coordinator for the county of San Diego and Rachel Jonas, left, a public health nurse, wheel doses of the Pfizer COVID-19 vaccine that arrived early Monday in San Diego County to pass them off to Nirmal Patel, not pictured, the director of pharmacy services, ambulatory pharmacy at Scripps Health, at an undisclosed county building
COVID-19 Vaccine Arrival, San Diego, Los Angeles, California, USA - 14 Dec 2020 -
DUK10147310_002
NEWS - Coronavirus: Vierte Impfdosen für über 60-Jährige in Israel
Mandatory Credit: Photo by Debbie Hill/UPI/Shutterstock (12685258e)
An Israeli health worker prepares a fourth Pfizer BioNTech vaccine for an elderly man in the Meuhedet Clinic in Jerusalem on Monday, January 3, 2022. Israel is the first in the world to administer the fourth COVID-19 vaccination for people over 60 and health workers.
COVID-19 vaccination, Jerusalem, Israel - 03 Jan 2022
(c) Dukas -
DUK10141218_013
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher holds a bottle with serum to be cataloged. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699879
(c) Dukas -
DUK10141218_009
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher removes the serum from the vial. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699878
(c) Dukas -
DUK10141218_003
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, arrival of CoronaVac vaccines. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699874
(c) Dukas -
DUK10141218_015
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher puts the serum in a new bottle. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699869
(c) Dukas -
DUK10141218_014
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699873
(c) Dukas -
DUK10141218_012
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, the application of the CoronaVac vaccine. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699876
(c) Dukas -
DUK10141218_011
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, the syringe with the dose of the CoronaVac vaccine. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699875
(c) Dukas -
DUK10141218_008
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher puts serum in a new bottle. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699872
(c) Dukas -
DUK10141218_007
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699877
(c) Dukas -
DUK10141218_005
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher removes serum from the vial with blood. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699868
(c) Dukas -
DUK10141218_004
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699882
(c) Dukas -
DUK10141218_002
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, the syringe with the dose of the CoronaVac vaccine. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699881
(c) Dukas -
DUK10141218_001
NEWS - Coronavirus: Brasilien - Amazonas startet CovacManaus-Studie
MANAUS, AM, BRAZIL - 20.03.2021: AMAZONAS STARTS COVACMANAUS STUDY - Amazonas started this Thursday, March 18, 2021, the CovacManaus study, which will carry out the anticipation of the vaccine against COVID-19 for education and public safety professionals from the state network, based in Manaus (AM), aged 18 and 49 years. This Saturday, March 20, 2021, were the servers with 48 years of age in Manus, Brazil. The vaccine doses of the study (CoronaVac), exclusive for use in research, are a donation from the Butantan Institute and the study is being carried out at the State University of Amazonas. In the photo, a researcher removes the bottles from the machine. (Photo: Sandro Pereira/Fotoarena/Sipa USA) *** Local Caption *** 32699880
(c) Dukas -
DUK10139939_013
NEWS - Coronavirus: Impfung von Betagten in Strasbourg
Illustration de la campagne de vaccination contre le coronavirus (COVID-19) dans l'Ehpad Laury Munch à Strasbourg le 31 janvier 2021. © Elyxandro Cegarra / Panoramic / Bestimage Illustration of the vaccination campaign against coronavirus (COVID-19) in the Ehpad Laury Munch in Strasbourg on 31 January 2021.
(c) Dukas -
DUK10139939_008
NEWS - Coronavirus: Impfung von Betagten in Strasbourg
Illustration de la campagne de vaccination contre le coronavirus (COVID-19) dans l'Ehpad Laury Munch à Strasbourg le 31 janvier 2021. © Elyxandro Cegarra / Panoramic / Bestimage Illustration of the vaccination campaign against coronavirus (COVID-19) in the Ehpad Laury Munch in Strasbourg on 31 January 2021.
(c) Dukas -
DUK10139939_007
NEWS - Coronavirus: Impfung von Betagten in Strasbourg
Illustration de la campagne de vaccination contre le coronavirus (COVID-19) dans l'Ehpad Laury Munch à Strasbourg le 31 janvier 2021. © Elyxandro Cegarra / Panoramic / Bestimage Illustration of the vaccination campaign against coronavirus (COVID-19) in the Ehpad Laury Munch in Strasbourg on 31 January 2021.
(c) Dukas -
DUK10138770_009
NEWS - Coronavirus: COVID-19-Impfstoff trifft in San Diego ein
Mandatory Credit: Photo by Sam Hodgson/The San Diego Union-Tribune/Shutterstock (11550113j)
Mariana Venegas, the vaccine and surge coordinator for the county of San Diego hands off doses of the Pfizer COVID-19 vaccine that arrived early Monday in San Diego County to Nirmal Patel, director of pharmacy services, ambulatory pharmacy at Scripps Health, at an undisclosed county building
COVID-19 Vaccine Arrival, San Diego, Los Angeles, California, USA - 14 Dec 2020 -
DUK10138770_007
NEWS - Coronavirus: COVID-19-Impfstoff trifft in San Diego ein
Mandatory Credit: Photo by Sam Hodgson/The San Diego Union-Tribune/Shutterstock (11550113i)
Mariana Venegas, the vaccine and surge coordinator for the county of San Diego hands off doses of the Pfizer COVID-19 vaccine that arrived early Monday in San Diego County to Nirmal Patel, director of pharmacy services, ambulatory pharmacy at Scripps Health, at an undisclosed county building
COVID-19 Vaccine Arrival, San Diego, Los Angeles, California, USA - 14 Dec 2020 -
DUK10138770_003
NEWS - Coronavirus: COVID-19-Impfstoff trifft in San Diego ein
Mandatory Credit: Photo by Sam Hodgson/The San Diego Union-Tribune/Shutterstock (11550113c)
Mariana Venegas, right, the vaccine and surge coordinator for the county of San Diego and Rachel Jonas, left, a public health nurse, wheel doses of the Pfizer COVID-19 vaccine that arrived early Monday in San Diego County to pass them off to Nirmal Patel, not pictured, the director of pharmacy services, ambulatory pharmacy at Scripps Health, at an undisclosed county building
COVID-19 Vaccine Arrival, San Diego, Los Angeles, California, USA - 14 Dec 2020 -
DUK10138770_001
NEWS - Coronavirus: COVID-19-Impfstoff trifft in San Diego ein
Mandatory Credit: Photo by Sam Hodgson/The San Diego Union-Tribune/Shutterstock (11550113g)
Mariana Venegas, the vaccine and surge coordinator for the county of San Diego hands off doses of the Pfizer COVID-19 vaccine that arrived early Monday in San Diego County to Nirmal Patel, director of pharmacy services, ambulatory pharmacy at Scripps Health, at an undisclosed county building
COVID-19 Vaccine Arrival, San Diego, Los Angeles, California, USA - 14 Dec 2020 -
DUK10138632_005
FEATURE - London erwacht im Nebel
Mandatory Credit: Photo by Alex Lentati/LNP/Shutterstock (11348128g)
Commuters head to work in the fog in Putney, South West London as the Met Office issue another yellow weather warning for freezing fog with disruption to transport for the South East of England this morning. Today a 90 year old grandmother, Margaret Keenan became the first person in the World to get an approved Pfizer Covid-19 vaccine as the government and NHS has kicked off the biggest vaccination drive in UK history.
Traffic builds up in thick fog as commuters head into London as the Met Office issue another yellow weather warning for fog, London, UK - 08 Dec 2020
(c) Dukas -
